Skip to content
Research Article Open access CC BY 4.0

Vaccine Hesitancy: In the Age of the COVID-19 Pandemic

Mohammad Jahidur Rahman Khan, Samshad Jahan Shumu, Farzana Mim, Md. Selim Reza

Asian Journal of Research in Infectious Diseases · pp. 9–16 · Published 18 Nov 2021

10.9734/ajrid/2021/v8i430243

Abstract

Vaccines are one of the most significant innovations of modern science. Worldwide, millions of lives are saved each year by the vaccine. Vaccine hesitancy, which represents the refusal to receive vaccines when vaccination services are available and reachable, is a major obstacle to global health. While vaccine hesitancy has been present for many years, its damaging effects are likely to be more evident during the COVID-19 pandemic than ever before. This study aimed to find out common causes of vaccine hesitancy, assess COVID-19 vaccination acceptance rates worldwide, and present the approaches by which vaccine hesitancy rate can be reduced. This study revealed though vaccine hesitancy is a worldwide phenomenon, the causes differ from country to country or reign. More studies are needed to address COVID-19 vaccine hesitancy, especially in the Middle and South America, the Middle East and North Africa, Central Asia, Sub-Saharan Africa, Eastern Europe. The leading causes of COVID-19 vaccine hesitancy are found lack of confidence towards the government or pharmaceutical companies, less concern about the outcome of SARS-CoV-2 infection, and shortage of supply of different types of COVID-19 vaccines. Healthcare personnel and social media play an essential role in addressing vaccine hesitancy. Convincing the general population about the safety and effectiveness of COVID-19 vaccines, the consequence of being unvaccinated, and the delivery of free vaccines in an easily accessible way can reduce vaccine hesitancy rate.

Vaccine, social media information science immunization program national vaccination campaign

References (34)

  1. 1 Vaccine hesitancy: Definition, scope and determinants [DOI]
  2. 2 A global survey of potential acceptance of a COVID-19 vaccine [DOI]
  3. 3 COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates [DOI]
  4. 4 Vaccine hesitancy: the next challenge in the fight against COVID-19 [DOI]
  5. 5 Determinants of COVID-19 vaccine acceptance in the US [DOI]
  6. 6 Vaccine hesitancy in the era of COVID-19 [DOI]
  7. 7 The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey [DOI]
  8. 8 Increasing Vaccination: Putting Psychological Science Into Action [DOI]
  9. 9 Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China [DOI]
  10. 10 Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey [DOI]
  11. 11 Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia [DOI]
  12. 12 COVID-19 and vaccine hesitancy: A longitudinal study [DOI]
  13. 13 High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries [DOI]
  14. 14 Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey [DOI]
  15. 15 Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination [DOI]
  16. 16 ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic [DOI]
  17. 17 COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries [DOI]
  18. 18 COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey [DOI]
  19. 19 Patient reminder and recall interventions to improve immunization rates [DOI]
  20. 20 Opting In vs Opting Out of Influenza Vaccination [DOI]
  21. 21 Intention to vaccinate against COVID-19 in Australia [DOI]
  22. 22 Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage [DOI]
  23. 23 Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis [DOI]
  24. 24 Vaccine hesitancy among parents in a multi-ethnic country, Malaysia [DOI]
  25. 25 Comparisons of Vaccine Hesitancy across Five Low- and Middle-Income Countries [DOI]
  26. 26 The demand for a COVID-19 vaccine in Ecuador [DOI]
  27. 27 Vaccine Hesitancy on Social Media: Sentiment Analysis from June 2011 to April 2019 [DOI]
  28. 28 COVID-19 Vaccine Hesitancy: Shortening the Last Mile [DOI]
  29. 29 Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program — United States, December 2020–January 2021 [DOI]
  30. 30 Attitudes towards influenza vaccine and a potential COVID-19 vaccine in Italy and differences across occupational groups, September 2020 [DOI]
  31. 31 Facebook and Twitter vaccine sentiment in response to measles outbreaks [DOI]
  32. 32 Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands, 2009 to 2011 [DOI]
  33. 33 How to Understand “Herd Immunity” in COVID-19 Pandemic [DOI]
  34. 34 Information Delivered by a Chatbot Has a Positive Impact on COVID-19 Vaccines Attitudes and Intentions [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

41

Page views

0

PDF downloads

12

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.